Email Us
Call Us
AUSTIN, Texas – October 21, 2025 – Altogen Labs has published technical documentation for its validated colorectal cancer xenograft models, including a review of xenografts that were used to dissect epigenetic control of tumor growth. Colorectal cancer presents a global health challenge driven by genetic mutations, environmental influences, and microenvironmental interactions, and is frequently diagnosed at advanced stages when treatment options narrow. Conventional in vitro models fall short of replicating the structural, microenvironmental, and therapeutic complexity of human tumors, which is why xenograft models remain central to translational colorectal research. The documentation reviews work in which lactoferrin was shown to suppress HT29 xenograft tumor growth in diabetic C57BL/6 and BALB/c nude mice, with efficacy enhanced in combination approaches. Mechanistic analysis implicated a WTAP/m6A/NT5DC3/HKDC1 regulatory axis, with 5-methylcytosine and N6-methyladenosine modifications altered at specific regulatory loci. Studies of this kind — combining in vivo efficacy with epigenetic and clinical correlative analysis — are exactly the multi-layer designs Altogen Labs is built to execute.
HT29 is one of fourteen validated colorectal models in the Altogen Labs collection, alongside HCT116, HCT-15, DLD-1, COLO-205, KM-12, LoVo, LS174T, RKO, SW480, SW620, WiDr, and the CT26 and MC38 syngeneic mouse models used extensively in immuno-oncology. Supporting services include custom cell line engineering with stable overexpression or RNAi-mediated silencing, mRNA quantification by RT-PCR, protein analysis by automated capillary Western, immunohistochemistry, and biomarker discovery workflows.
About Altogen Labs Altogen Labs is a professional, experienced, and highly reputable GLP-compliant contract research organization providing preclinical research and biology CRO services to pharmaceutical, biotechnology, and academic institutions worldwide, with a large collection of validated xenograft models and extensive experience in efficacy xenograft and safety toxicology studies.
Contact Information: Altogen Labs | 11200 Menchaca Rd, Bldg 2, Suite 203 | Austin, TX 78748 USA Tel: 512-433-6177 | Email: info@altogenlabs.com | Web: altogenlabs.com